RT @dr_michaelmarks: Important data showing #COVID19 antibodies associated lower risk symptomatic & asymptomatic infection in HCWs https://…
Interesting large COVID infection study of Health Care Workers in Oxford. They followed 12.000 of them and tracked their antibody status for 6 months. Found 89 infections in the non-antibody group, and no symptomatic ones in group with antibodies. https://
RT @JeremyFarrar: Antibodies to SARS-CoV-2 are associated with protection against reinfection https://t.co/OXVAzmB5F6
Some relatively good news: 'Prior SARS-CoV-2 infection that generated antibody responses offered protection from reinfection for most people in the six months following infection.'
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
What a beautifully written paper - with very encouraging results! @SheilaLumley @drdavideyre Antibodies to SARS-CoV-2 are associated with protection against reinfection https://t.co/eQG84Ntx4q
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
This manuscript (sure we see it published in next weeks in a journal) gives a clear and potent message about reinfection #SARSCoV2: prospective design, 30w follow-up. PCR+: 0.00/10,000 days-at-risk in seropositive individuals (n=3) Congrats! @UnioOxford @S
الاجسام المضادة لكوفيد١٩ تقي من الإصابة المتكررة بفيروس #كوفيد١٩. في هذه الدراسة قام الباحثون بمتابعة عدد كبير من العاملين في القطاع الصحي لفترة امتدت لستة اشهر. ١/٢ https://t.co/azSUYiWsJg https://t.co/VxnXm6Ogdj
RT @JeremyFarrar: Antibodies to SARS-CoV-2 are associated with protection against reinfection https://t.co/OXVAzmB5F6
RT @JeremyFarrar: Antibodies to SARS-CoV-2 are associated with protection against reinfection https://t.co/OXVAzmB5F6
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
Antibodies to SARS-CoV-2 are associated with protection against reinfection | medRxiv https://t.co/TBRV1NJvWX
Antibodies to SARS-CoV-2 are associated with protection against reinfection | medRxiv @wherepond https://t.co/TBRV1NJvWX
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT @SheilaLumley: Protection from #SARSCoV2 reinfection, for at least 6 months, for most people - major implications for the future of the…
RT @JeremyFarrar: Antibodies to SARS-CoV-2 are associated with protection against reinfection https://t.co/OXVAzmB5F6
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT @JeremyFarrar: Antibodies to SARS-CoV-2 are associated with protection against reinfection https://t.co/OXVAzmB5F6
RT @JeremyFarrar: Antibodies to SARS-CoV-2 are associated with protection against reinfection https://t.co/OXVAzmB5F6
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT FranciscoMarty_ https://t.co/1ioiHhjk0V "RT dr_michaelmarks: Important data showing #COVID19 antibodies associated lower risk symptomatic & asymptomatic infection in HCWs https://…"
RT K_G_Andersen https://t.co/GiLOzPN1C7 "RT EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…"
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
At last good news.
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT @dr_michaelmarks: Important data showing #COVID19 antibodies associated lower risk symptomatic & asymptomatic infection in HCWs https://…
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT @KatieJeffery10: Antibodies to SARS-CoV-2 are associated with protection against reinfection! https://t.co/jTRchrSo2E @OUH_Research @drd…
The paper “Antibodies to SARS-CoV-2 are associated with prote...” (https://t.co/3Z5ws0tfhf) has been reviewed by a set of automated tools; find the results of the analysis here: https://t.co/tAskI5jMur. We detected 3 of 5 rigor criteria and 11 key resource
RT @PeterHorby: More good news. Antibodies to SARS-CoV-2 are associated with protection against reinfection https://t.co/qyC0x5RCg1 https:/…
RT @drdavideyre: Can you catch #COVID again? It's very unlikely, at least for 6 months: 89 symptomatic infections in 11,052 healthcare work…
The good news about protective immunity against #covid19 #coronavirus reinfection just keeps rolling in.
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT @JeremyFarrar: Antibodies to SARS-CoV-2 are associated with protection against reinfection https://t.co/OXVAzmB5F6
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT @florian_krammer: Nice!
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
“Prior SARS-CoV-2 infection that generated antibody responses offered protection from reinfection for most people in the six months following infection.” https://t.co/tKeve7JWE7
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT @JeremyFarrar: Antibodies to SARS-CoV-2 are associated with protection against reinfection https://t.co/OXVAzmB5F6
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
Éric Topol: La meilleure étude prospective sur la réinfection à ce jour montre à quel point elle est rare dans les 6 mois, fortement influencée par la réponse anticorps de base (> 11 000 agents de santé). Zéro symptomatique w / Ab. https://t.co/Op0gzZyY
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT @EricTopol: The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibo…
RT EckerleIsabella https://t.co/6qsjEsCma1 "RT JeremyFarrar: Antibodies to SARS-CoV-2 are associated with protection against reinfection https://t.co/9tqyjXSeDQ"
RT @JeremyFarrar: Antibodies to SARS-CoV-2 are associated with protection against reinfection https://t.co/OXVAzmB5F6
The best prospective study on reinfection to date shows how rare it is within 6 months, highly influenced by baseline antibody response (>11,000 healthcare workers). Zero symptomatic w/ Ab. https://t.co/68Mtn2g7WB @UniofOxford @SheilaLumley @drdavideyre
RT @xsaezll: presencia de anticuerpos contra proteina S del virus protege contra infección (sintomática o asintomática) y contra reinfecció…
RT @LucreSnooker: data out of Oxford University hospitals: among healthcare workers who tested positive for antibodies at baseline (around…
RT @JeremyFarrar: Antibodies to SARS-CoV-2 are associated with protection against reinfection https://t.co/OXVAzmB5F6
👇🏻Now that is good news. Just need to ensure the false positive of c.20% on the antibody test doesn’t breed complacency. #covid
RT @LucreSnooker: data out of Oxford University hospitals: among healthcare workers who tested positive for antibodies at baseline (around…
RT @JeremyFarrar: Antibodies to SARS-CoV-2 are associated with protection against reinfection https://t.co/OXVAzmB5F6
data out of Oxford University hospitals: among healthcare workers who tested positive for antibodies at baseline (around April), none had symptomatic infections through Nov, but asymptomatic infections perhaps starting to pick up https://t.co/M0w78N8wKv ht
RT @drdavideyre: Can you catch #COVID again? It's very unlikely, at least for 6 months: 89 symptomatic infections in 11,052 healthcare work…
RT @florian_krammer: Nice!
RT @xsaezll: presencia de anticuerpos contra proteina S del virus protege contra infección (sintomática o asintomática) y contra reinfecció…
RT @drdavideyre: Can you catch #COVID again? It's very unlikely, at least for 6 months: 89 symptomatic infections in 11,052 healthcare work…
👍🏻
for 6 months so far... But very good news
“Conclusions Prior SARS-CoV-2 infection that generated antibody responses offered protection from reinfection for most people in the six months following infection.” https://t.co/6iBTXtIYSh
RT @JeremyFarrar: Antibodies to SARS-CoV-2 are associated with protection against reinfection https://t.co/OXVAzmB5F6
RT @DrAdamBat: الذين يصابون بالفيروس ويكوّنون اجسام مضادة لديهم مناعة تستمر ٦ اشهر على الاقل حسب دراسة جديدة https://t.co/hcqd5hHqSd ملاح…
RT @JeremyFarrar: Antibodies to SARS-CoV-2 are associated with protection against reinfection https://t.co/OXVAzmB5F6
Nice! Avoir les anticorps contre Sars-CoV-2 protegent contre la re-infection. Maintenant, il reste a determiner combien de temps cette immunite persiste.
RT @xsaezll: presencia de anticuerpos contra proteina S del virus protege contra infección (sintomática o asintomática) y contra reinfecció…
RT @JeremyFarrar: Antibodies to SARS-CoV-2 are associated with protection against reinfection https://t.co/OXVAzmB5F6
RT @JeremyFarrar: Antibodies to SARS-CoV-2 are associated with protection against reinfection https://t.co/OXVAzmB5F6
RT @PeterHorby: More good news. Antibodies to SARS-CoV-2 are associated with protection against reinfection https://t.co/qyC0x5RCg1 https:/…
RT @iamritu: Prior #SARSCoV2 infection that makes AB,assoc w protection from reinfection in HCWs @medrxivpreprint https://t.co/uONAYNRm9m…
RT @JeremyFarrar: Antibodies to SARS-CoV-2 are associated with protection against reinfection https://t.co/OXVAzmB5F6
RT @JeremyFarrar: Antibodies to SARS-CoV-2 are associated with protection against reinfection https://t.co/OXVAzmB5F6
RT @florian_krammer: Nice!
RT @JeremyFarrar: Antibodies to SARS-CoV-2 are associated with protection against reinfection https://t.co/OXVAzmB5F6
@pbleic https://t.co/8rYGFWQ8mn Did you see this paper?